In one fell swoop today, Sen. David Vitter (R-LA) revived the specter of health care death panels, and called into question the FDA’s ability to judge the effectiveness of breast cancer medication.
This is a companion discussion topic for the original entry at https://talkingpointsmemo.com/?p=123380